$53.22 +0.15 (%) HCC Insurance Holdings Inc - NYSE

Dec. 18, 2014 | 04:00 PM

Partner Headlines

  1. 9 Dividend Stocks Providing an Inflation Hedge with Increased Dividends

    GuruFocus | Aug. 26, 2013 | 14:47PM EST
  2. UPDATE: Goldman Sachs Reiterates Neutral Rating, Raises PT on HCC Insurance Holdings After 4Q12 Earnings

    Benzinga | Feb. 15, 2013 | 06:21AM EST
  3. Earnings Scheduled For February 12, 2013

    Benzinga | Feb. 11, 2013 | 19:49PM EST
  4. HCC Insurance Holdings Inc. (HCC) CEO John Niels Jr Molbeck sells 15,600 Shares

    GuruFocus | Nov. 21, 2012 | 04:35AM EST
  5. Superstorm Sandy Hits ETFs

    FoxBusiness | Nov. 19, 2012 | 03:50AM EST
  6. HCC Insurance Holdings Inc. (HCC) Executive Vice President & CFO Brad T Irick sells 20,000 ...

    GuruFocus | Nov. 14, 2012 | 06:36AM EST
  7. HCC Insurance Holdings Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 6, 2012 | 04:35AM EST
  8. HCC to Move Forward with Succession Plan

    Benzinga | Oct. 2, 2012 | 14:27PM EST
  9. 20 Of The Best Performing Dividend Achievers With Still Cheap Earnings Multiples

    GuruFocus | Sep. 29, 2012 | 04:16AM EST
  10. How to Look Beyond Dividend Increases

    GuruFocus | Aug. 27, 2012 | 04:58AM EST
  11. HCC Insurance Announces Increase in Quarterly Dividend to $0.165 per $1.00 of Common Stock

    Benzinga | Aug. 23, 2012 | 11:02AM EST
  12. HCC Insurance Holdings Inc. Reports Operating Results (10-Q)

    GuruFocus | Aug. 3, 2012 | 14:25PM EST
  13. HCC Insurance Holdings Inc. (HCC) CEO John Niels Jr Molbeck sells 32,047 Shares

    GuruFocus | Feb. 24, 2012 | 10:40AM EST
  14. BGB Securities Maintains Buy Rating on HCC Insurance Holdings

    Benzinga | Feb. 23, 2012 | 07:59AM EST
  15. Top Growth Stocks from John Rogers

    GuruFocus | Feb. 13, 2012 | 11:34AM EST
  16. HCC Announces Preliminary Fourth Quarter 2011 Catastrophe Loss Estimate of $10M

    Benzinga | Jan. 24, 2012 | 10:00AM EST
  17. Top 4 Mid-Cap Stocks In The Property & Casualty Insurance Industry With The Highest Profit Margin

    Benzinga | Jan. 18, 2012 | 21:14PM EST
  18. ArQule Up 15% After Liver Cancer Drug Meets Endpoints

    Benzinga | Jan. 17, 2012 | 07:18AM EST
Trading Center